RemeGen Co Eulerpool News

RemeGen Co Aktie News

RemeGen Co wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten RemeGen Co News stellen wir hier zusammen.

• 16. Juni ·

  Yahoo
  Asian Growth Stocks Insiders Own With Up To 32% Return On Equity
• 27. Mai ·

  Yahoo
  RemeGen: Telitacicept for the Treatment of Generalized Myasthenia Gravis Approved in China
• 26. Mai ·

  Yahoo
  3 Asian Stocks Estimated To Be Trading Below Intrinsic Value In May 2025
• 19. Mai ·

  Yahoo
  3 Asian Growth Companies With Significant Insider Ownership
• 12. Mai ·

  Yahoo
  Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic ‌Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS
• 9. Mai ·

  SeekingAlpha
  Biotech Outperformance - Can't Take What's Already Earned
• 2. April ·

  Yahoo
  3 Asian Stocks That May Be Trading Below Intrinsic Value By Up To 49%
• 20. März ·

  Yahoo
  Asian Growth Companies With High Insider Ownership For March 2025
• 19. Februar ·

  Yahoo
  3 Growth Companies With High Insider Ownership And 229% Earnings Growth
• 8. Januar ·

  Yahoo
  Published in Annals of Oncology: Disitamab Vedotin Combined with PD-1 Inhibitor is a Promising Treatment for Locally Advanced or Metastatic Urothelial Carcinoma